We are live on ! Find out more
LAB icon

Standard BioTools
LAB

104 hedge funds and large institutions have $788M invested in Standard BioTools in 2014 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

131% more call options, than puts

Call options by funds: $23.5M | Put options by funds: $10.2M

17% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 35

3% less funds holding

Funds holding: 107 → 104 (-3)

12% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 26

32% less capital invested

Capital invested by funds: $1.15B → $788M (-$366M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
104
Holders Change
-3
Holders Change %
-2.8%
% of All Funds
2.99%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
41
Reduced
35
Closed
26
Calls
$23.5M
Puts
$10.2M
Net Calls
+$13.3M
Net Calls Change
-$10.1M

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$38.4M
2
O
OrbiMed
New York
+$13.3M
3
RG
Redmile Group
California
+$12.6M
4
CGI
CI Global Investments
California
+$9.61M
5
Franklin Resources
Franklin Resources
California
+$8.59M

Top Sellers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$20.6M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$17.4M
3
O
OppenheimerFunds
New York
-$12.8M
4
CCM
Cupps Capital Management
Illinois
-$9.64M
5
Invesco
Invesco
Georgia
-$8.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$4.48M -$9.16K -286 -0.2%
O
27
OppenheimerFunds
New York
$4.36M -$12.8M -398,512 -73%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$4.23M -$289K -9,008 -6%
Allianz Asset Management
29
Allianz Asset Management
Germany
$3.48M -$2.31M -72,153 -38%
CS
30
Credit Suisse
Switzerland
$3.35M +$1.88M +58,569 +106%
TCIM
31
TIAA CREF Investment Management
New York
$3.3M +$215K +6,725 +6%
ICM
32
IronBridge Capital Management
Illinois
$3.26M +$1.82M +56,883 +105%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$3.06M +$2.43M +75,912 +270%
CCM
34
Cupps Capital Management
Illinois
$3.04M -$9.64M -300,796 -74%
VAM
35
Visium Asset Management
New York
$2.8M -$8.58M -267,790 -74%
ECP
36
Elk Creek Partners
Colorado
$2.78M +$3.03M +94,547 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$2.5M -$47.6K -1,484 -2%
Stifel Financial
38
Stifel Financial
Missouri
$2.44M +$317K +9,886 +14%
BIM
39
BlackRock Investment Management
Delaware
$2.38M +$351K +10,951 +16%
Charles Schwab
40
Charles Schwab
California
$2.13M -$6.86K -214 -0.3%
FLAM
41
First Light Asset Management
Minnesota
$2.13M +$129K +4,036 +6%
Principal Financial Group
42
Principal Financial Group
Iowa
$2.08M -$255K -7,959 -10%
WSA
43
Wall Street Associates
California
$2.03M -$240K -7,500 -10%
DCM
44
Driehaus Capital Management
Illinois
$1.89M -$3.84M -119,691 -65%
1832 Asset Management
45
1832 Asset Management
Ontario, Canada
$1.87M +$218K +6,800 +12%
NI
46
Numeric Investors
Massachusetts
$1.79M +$1.95M +61,000 New
VFA
47
Virtus Fund Advisers
Connecticut
$1.63M +$1.78M +55,486 New
KIA
48
Kopp Investment Advisors
Minnesota
$1.6M +$173K +5,403 +11%
Ohio Public Employees Retirement System (OPERS)
49
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.56M – – –
Goldman Sachs
50
Goldman Sachs
New York
$1.51M +$80.2K +2,504 +5%
1
2
3 4 5

LAB Hedge Fund Activity: Q2 2014 in Review

104 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2014, worth a combined $788M — down 32% from $1.15B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of LAB and 23 opened new positions — a net loss of 3 holders — while 35 trimmed existing stakes and 41 added.

The largest buyer was JP Morgan Chase, adding an estimated $38.4M. The largest seller was Lord, Abbett & Co, cutting an estimated $20.6M.

  • 104 institutional investors held Standard BioTools (LAB) as of Q2 2014, down from 107 in Q1 2014.
  • Funds reported $788M of Standard BioTools stock for Q2 2014, down 32% quarter-over-quarter.
  • 23 funds opened new Standard BioTools positions in Q2 2014 and 26 closed out, a net change of -3 holders.
  • The largest Standard BioTools buyer in Q2 2014 was JP Morgan Chase, an estimated $38.4M added.
  • The largest Standard BioTools seller in Q2 2014 was Lord, Abbett & Co, an estimated $20.6M sold.

Based on aggregated 13F filings for Q2 2014.